Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.

RTS,S is the most advanced malaria vaccine candidate, currently under phase-III clinical trials in Africa. This Plasmodium falciparum vaccine contains part of the central repeat region and the complete C-terminal T cell epitope region (Th2R and Th3R) of the circumsporozoite protein (CSP). Since natu...

Full description

Bibliographic Details
Main Authors: Mohammad Zeeshan, Mohammad Tauqeer Alam, Sumiti Vinayak, Hema Bora, Rupesh Kumar Tyagi, Mohd Shoeb Alam, Vandana Choudhary, Pooja Mittra, Vanshika Lumb, Praveen Kumar Bharti, Venkatachalam Udhayakumar, Neeru Singh, Vidhan Jain, Pushpendra Pal Singh, Yagya Dutta Sharma
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22912873/?tool=EBI
_version_ 1828959412278001664
author Mohammad Zeeshan
Mohammad Tauqeer Alam
Sumiti Vinayak
Hema Bora
Rupesh Kumar Tyagi
Mohd Shoeb Alam
Vandana Choudhary
Pooja Mittra
Vanshika Lumb
Praveen Kumar Bharti
Venkatachalam Udhayakumar
Neeru Singh
Vidhan Jain
Pushpendra Pal Singh
Yagya Dutta Sharma
author_facet Mohammad Zeeshan
Mohammad Tauqeer Alam
Sumiti Vinayak
Hema Bora
Rupesh Kumar Tyagi
Mohd Shoeb Alam
Vandana Choudhary
Pooja Mittra
Vanshika Lumb
Praveen Kumar Bharti
Venkatachalam Udhayakumar
Neeru Singh
Vidhan Jain
Pushpendra Pal Singh
Yagya Dutta Sharma
author_sort Mohammad Zeeshan
collection DOAJ
description RTS,S is the most advanced malaria vaccine candidate, currently under phase-III clinical trials in Africa. This Plasmodium falciparum vaccine contains part of the central repeat region and the complete C-terminal T cell epitope region (Th2R and Th3R) of the circumsporozoite protein (CSP). Since naturally occurring polymorphisms at the vaccine candidate loci are critical determinants of the protective efficacy of the vaccines, it is imperative to investigate these polymorphisms in field isolates. In this study we have investigated the genetic diversity at the central repeat, C-terminal T cell epitope (Th2R and Th3R) and N-terminal T cell epitope regions of the CSP, in P. falciparum isolates from Madhya Pradesh state of India. These isolates were collected through a 5-year prospective study aimed to develop a well-characterized field-site for the future evaluation of malaria vaccine in India. Our results revealed that the central repeat (63 haplotypes, n = 161) and C-terminal Th2R/Th3R epitope (24 haplotypes, n = 179) regions were highly polymorphic, whereas N-terminal non-repeat region was less polymorphic (5 haplotypes, n = 161) in this population. We did not find any evidence of the role of positive natural selection in maintaining the genetic diversity at the Th2R/Th3R regions of CSP. Comparative analysis of the Th2R/Th3R sequences from this study to the global isolates (n = 1160) retrieved from the GenBank database revealed two important points. First, the majority of the sequences (~61%, n = 179) from this study were identical to the Dd2/Indochina type, which is also the predominant Th2R/Th3R haplotype in Asia (~59%, n = 974). Second, the Th2R/Th3R sequences in Asia, South America and Africa are geographically distinct with little allele sharing between continents. In conclusion, this study provides an insight on the existing polymorphisms in the CSP in a parasite population from India that could potentially influence the efficacy of RTS,S vaccine in this region.
first_indexed 2024-12-14T09:06:25Z
format Article
id doaj.art-e93356ca7e9d4fa895a299418020c96b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T09:06:25Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e93356ca7e9d4fa895a299418020c96b2022-12-21T23:08:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0178e4343010.1371/journal.pone.0043430Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.Mohammad ZeeshanMohammad Tauqeer AlamSumiti VinayakHema BoraRupesh Kumar TyagiMohd Shoeb AlamVandana ChoudharyPooja MittraVanshika LumbPraveen Kumar BhartiVenkatachalam UdhayakumarNeeru SinghVidhan JainPushpendra Pal SinghYagya Dutta SharmaRTS,S is the most advanced malaria vaccine candidate, currently under phase-III clinical trials in Africa. This Plasmodium falciparum vaccine contains part of the central repeat region and the complete C-terminal T cell epitope region (Th2R and Th3R) of the circumsporozoite protein (CSP). Since naturally occurring polymorphisms at the vaccine candidate loci are critical determinants of the protective efficacy of the vaccines, it is imperative to investigate these polymorphisms in field isolates. In this study we have investigated the genetic diversity at the central repeat, C-terminal T cell epitope (Th2R and Th3R) and N-terminal T cell epitope regions of the CSP, in P. falciparum isolates from Madhya Pradesh state of India. These isolates were collected through a 5-year prospective study aimed to develop a well-characterized field-site for the future evaluation of malaria vaccine in India. Our results revealed that the central repeat (63 haplotypes, n = 161) and C-terminal Th2R/Th3R epitope (24 haplotypes, n = 179) regions were highly polymorphic, whereas N-terminal non-repeat region was less polymorphic (5 haplotypes, n = 161) in this population. We did not find any evidence of the role of positive natural selection in maintaining the genetic diversity at the Th2R/Th3R regions of CSP. Comparative analysis of the Th2R/Th3R sequences from this study to the global isolates (n = 1160) retrieved from the GenBank database revealed two important points. First, the majority of the sequences (~61%, n = 179) from this study were identical to the Dd2/Indochina type, which is also the predominant Th2R/Th3R haplotype in Asia (~59%, n = 974). Second, the Th2R/Th3R sequences in Asia, South America and Africa are geographically distinct with little allele sharing between continents. In conclusion, this study provides an insight on the existing polymorphisms in the CSP in a parasite population from India that could potentially influence the efficacy of RTS,S vaccine in this region.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22912873/?tool=EBI
spellingShingle Mohammad Zeeshan
Mohammad Tauqeer Alam
Sumiti Vinayak
Hema Bora
Rupesh Kumar Tyagi
Mohd Shoeb Alam
Vandana Choudhary
Pooja Mittra
Vanshika Lumb
Praveen Kumar Bharti
Venkatachalam Udhayakumar
Neeru Singh
Vidhan Jain
Pushpendra Pal Singh
Yagya Dutta Sharma
Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
PLoS ONE
title Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
title_full Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
title_fullStr Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
title_full_unstemmed Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
title_short Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
title_sort genetic variation in the plasmodium falciparum circumsporozoite protein in india and its relevance to rts s malaria vaccine
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22912873/?tool=EBI
work_keys_str_mv AT mohammadzeeshan geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine
AT mohammadtauqeeralam geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine
AT sumitivinayak geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine
AT hemabora geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine
AT rupeshkumartyagi geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine
AT mohdshoebalam geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine
AT vandanachoudhary geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine
AT poojamittra geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine
AT vanshikalumb geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine
AT praveenkumarbharti geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine
AT venkatachalamudhayakumar geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine
AT neerusingh geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine
AT vidhanjain geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine
AT pushpendrapalsingh geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine
AT yagyaduttasharma geneticvariationintheplasmodiumfalciparumcircumsporozoiteproteininindiaanditsrelevancetortssmalariavaccine